1. Home
  2. NEOG

as 12-17-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Founded: 1981 Country:
United States
United States
Employees: N/A City: LANSING
Market Cap: 3.2B IPO Year: 1989
Target Price: $17.50 AVG Volume (30 days): 1.8M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.11 EPS Growth: N/A
52 Week Low/High: $11.46 - $20.89 Next Earning Date: 01-07-2025
Revenue: $912,199,000 Revenue Growth: -0.75%
Revenue Growth (this year): 5.11% Revenue Growth (next year): 4.79%

NEOG Daily Stock ML Predictions

Stock Insider Trading Activity of Neogen Corporation (NEOG)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
ADENT JOHN EDWARD NEOG CEO Oct 11 '24 Buy $13.80 14,500 $200,100.00 216,477

Share on Social Networks: